302 related articles for article (PubMed ID: 24083670)
1. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.
Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY;
Trials; 2013 Oct; 14():317. PubMed ID: 24083670
[TBL] [Abstract][Full Text] [Related]
2. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke.
Chung JW; Chang WH; Bang OY; Moon GJ; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH;
Neurology; 2021 Feb; 96(7):e1012-e1023. PubMed ID: 33472925
[TBL] [Abstract][Full Text] [Related]
4. Circulating Extracellular Vesicles in Stroke Patients Treated With Mesenchymal Stem Cells: A Biomarker Analysis of a Randomized Trial.
Bang OY; Kim EH; Cho YH; Oh MJ; Chung JW; Chang WH; Kim YH; Yang SW; Chopp M
Stroke; 2022 Jul; 53(7):2276-2286. PubMed ID: 35341320
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study.
Lee J; Chang WH; Chung JW; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH; Bang OY;
Stroke; 2022 Jan; 53(1):20-28. PubMed ID: 34583525
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
8. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
Trials; 2019 May; 20(1):263. PubMed ID: 31072380
[TBL] [Abstract][Full Text] [Related]
9. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.
Lee JS; Hong JM; Moon GJ; Lee PH; Ahn YH; Bang OY;
Stem Cells; 2010 Jun; 28(6):1099-106. PubMed ID: 20506226
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
11. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial.
Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O;
Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427
[TBL] [Abstract][Full Text] [Related]
12. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.
Honmou O; Houkin K; Matsunaga T; Niitsu Y; Ishiai S; Onodera R; Waxman SG; Kocsis JD
Brain; 2011 Jun; 134(Pt 6):1790-807. PubMed ID: 21493695
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
[TBL] [Abstract][Full Text] [Related]
15. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
[TBL] [Abstract][Full Text] [Related]
16. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.
Harris VK; Stark J; Williams A; Roche M; Malin M; Kumar A; Carlson AL; Kizilbash C; Wollowitz J; Andy C; Gerber LM; Sadiq SA
Stem Cell Res Ther; 2024 May; 15(1):151. PubMed ID: 38783390
[TBL] [Abstract][Full Text] [Related]
18. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.
Moon GJ; Cho YH; Kim DH; Sung JH; Son JP; Kim S; Cha JM; Bang OY
Cell Transplant; 2018 Mar; 27(3):485-500. PubMed ID: 29774769
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
[TBL] [Abstract][Full Text] [Related]
20. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
Lee WS; Kim HJ; Kim KI; Kim GB; Jin W
Stem Cells Transl Med; 2019 Jun; 8(6):504-511. PubMed ID: 30835956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
